ASX Release | 25 September 2026 ASX:NXN | Nexsen Limited | ACN 655182497 1 Proposed FlashDx joint venture builds on CE-marked GBS test Highlights: • Joint venture builds on existing CE-marked GBS test Proposed 50:50 joint venture (“JV”) will use FlashDx’s existing CE-marked...
Proposed FlashDx joint venture builds on CE-marked GBS test
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nexsen
- Suspension from Quotation
- Clear pathway defined to optimise StrepSure
- Trading Halt
- Director Interest Notices re Performance Rights
- Notification regarding unquoted securities - NXN
Later from Nexsen
- Reinstatement to Quotation
- Professor Shekhar Kumta appointed Executive Director
- Notice of AGM and Meeting Materials
- Quarterly Report - Q1 FY27
- ISO 13485 Certification brings StrepSure closer to market
Follow Nexsen into a list and get an email when it puts out news.
Follow Nexsen